| Use of dietary and performance-enhancing supplements among male fitness center members in Riyadh: A cross-sectional study Y AlRuthia, B Balkhi, M Alrasheed, A Altuwaijri, M Alarifi, H Alzahrani, ... PloS one 13 (6), e0199289, 2018 | 22 | 2018 |
| Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018 M Alrasheed, AL Hincapie, JJ Guo The Journal of Mental Health Policy and Economics 24 (1), 3-11, 2021 | 14 | 2021 |
| The effect of polypharmacy on quality of life in adult patients with nonalcoholic fatty liver disease in the United States M Alrasheed, JJ Guo, AC Lin, PR Wigle, A Hardee, AL Hincapie Quality of Life Research 31 (8), 2481-2491, 2022 | 11 | 2022 |
| Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020 A Alsuhibani, M Alrasheed, M Gari, AL Hincapie, JJ Guo International Journal of Clinical Pharmacy, 1-8, 2022 | 8 | 2022 |
| Continuous quality improvement regulations for community pharmacy practice in the United States AL Hincapie, F Alyami, M Alrasheed, M Hegener, C Beaton, L O’Brien, ... Journal of the American Pharmacists Association 61 (4), 470-475. e2, 2021 | 3 | 2021 |
| Dalbavancin for the treatment of bone and joint infections: A meta-analysis TA Almangour, MA Alrasheed Journal of Infection and Chemotherapy, 2024 | 1 | 2024 |
| Novel β-lactam-β-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: A multicenter cohort study TA Almangour, L Ghonem, D Alassiri, A Aljurbua, M Al Musawa, A Alharbi, ... Journal of Infection and Chemotherapy, 2024 | 1 | 2024 |
| Safety evaluation of panobinostat, ixazomib, elotuzumab, and daratumumab using FDA adverse event reporting system (FAERS) database 2015-2020 M Alrasheed, A Alsuhibani, AL Hincapie, J Guo PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 333-333, 2021 | 1 | 2021 |
| Comparison of quality of life between men and women with chronic liver diseases using chronic liver disease questionnaire (CLDQ): A meta-analysis M Alrasheed, A Alsuhibani, AL Hincapie, J Welge Pharmacoepidemiology and Drug Safety 30, 181-181, 2021 | 1 | 2021 |
| Pmh16 drug expenditure, price, and utilization in the US medicaid program: an empirical trend analysis for selective serotonin reuptake inhibitors (ssris) and serotonin … M Alrasheed, A Hincapie, JJ Guo Value in Health 23, S202-S203, 2020 | 1 | 2020 |
| Knowledge and perceptions of health literacy among pharmacists in Ohio in 2013 and 2021 K Kim, AM Metzger, MT Win, M Luck, M Alrasheed Journal of the American Pharmacists Association 65 (1), 102260, 2025 | | 2025 |
| Knowledge and Perception of Pharmacy Students toward Telepharmacy Education in Saudi Arabia MM Alsultan, MA Baraka, AK Alahmari, ME Elrggal, MA Mahmoud, ... Healthcare 12 (18), 1806, 2024 | | 2024 |
| Privacy in Community Pharmacies in Saudi Arabia: A Cross-Sectional Study MA Alrasheed, BH Alfageh, OA Almohammed Healthcare 12 (17), 1740, 2024 | | 2024 |
| Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022 MA Alrasheed, KA Alamer, M Albishi, AA Alsuhibani, OA Almohammed, ... Pharmaceuticals 17 (7), 815, 2024 | | 2024 |
| Understanding the Quality of Life Among Patients With Cancer in Saudi Arabia: Insights From a Cross-Sectional Study MH Aljawadi, N Alkhudair, M Alrasheed, AS Alsuhaibani, BJ Alotaibi, ... Cancer Control 31, 10732748241263013, 2024 | | 2024 |
| Pharmacy students’ interprofessional experience and performance in advanced pharmacy practice experience rotations amid COVID-19 pandemic M Alrasheed, A Alsuhibani, W Alotaibi, M Gari, A Alashgar, M Doherty, ... Frontiers in Medicine 11, 1394652, 2024 | | 2024 |
| Community pharmacist intervention in doxycycline self-medication for acne among pregnant women in Saudi Arabia M Alrasheed, WH Mansy, MN Al-Arifi Saudi Pharmaceutical Journal 32 (5), 102027, 2024 | | 2024 |
| Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022 M Alrasheed, A Alsuhibani, B Balkhi, JJ Guo Healthcare 11 (16), 2265, 2023 | | 2023 |
| EPH58 Adverse Events Associated with Sodium Glucose Co-Transporter-2 Inhibitors: A Pharmacoepidemiologic Analysis Using FAERS Database 2012-2022 M Gari, M Alrasheed, JJ Guo Value in Health 26 (6), S175, 2023 | | 2023 |
| Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States M Alrasheed, JJ Guo, AC Lin, PR Wigle, A Hardee, AL Hincapie Drugs & Therapy Perspectives 38 (11), 490-498, 2022 | | 2022 |
